Nano-X Imaging grants Dara James 28,283 stock units
The GM Source & Services Division officer's listed option positions include 100,000 shares at $49.68 and 55,000 shares at $11.52.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nano-X Imaging Ltd. officer Dara James, whose title is GM Source & Services Division, received a grant of 28,283 restricted share units (RSUs) on October 11, 2026, under the 2019 Equity Incentive Plan. The RSUs vest and settle for ordinary shares in four equal semi-annual installments of 25% on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject in each case to Dara James’s continued employment by Nano-X Imaging Ltd.
Insider Trade Summary
Grant/Award: 28,283 shares
Grant/Award
6 txns
Insider
Dara James
Role
GM Source & Services Division
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 28,283 | $0.00 | $0.00 |
| holding | Stock Option (right to buy ordinary shares) F3, F5 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F6 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F7 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F8 | -- | -- | -- |
| holding | Ordinary Shares F3, F4 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 67,757 shares (Direct);
Stock Option (right to buy ordinary shares) — 190,000 contracts (Direct)
Footnotes (8)
- F1. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
- F2. The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.
- F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
- F6. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.
- F7. The options reported in this row were granted to the Reporting Person by the Issuer on August 11, 2022 and are fully vested and exercisable as of the date of this report.
- F8. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
Key Figures
RSUs granted: 28,283 restricted share units
Option underlying ordinary shares: 100,000 shares
Option underlying ordinary shares: 25,000 shares
+2 more
5 metrics
RSUs granted
28,283 restricted share units
Granted to Dara James on October 11, 2026, under the 2019 Equity Incentive Plan
Option underlying ordinary shares
100,000 shares
Direct options; exercise price $49.68; expiration January 18, 2031
Option underlying ordinary shares
25,000 shares
Direct options; exercise price $17.63; expiration March 28, 2032
Option underlying ordinary shares
10,000 shares
Direct options; exercise price $17.63; expiration August 11, 2032
Option underlying ordinary shares
55,000 shares
Direct options; exercise price $11.52; expiration May 23, 2033
Key Terms
restricted share units, 2019 Equity Incentive Plan, semi-annual installments, fully vested and exercisable
4 terms
2019 Equity Incentive Plan financial
"pursuant to the Issuer's 2019 Equity Incentive Plan"
semi-annual installments financial
"four equal semi-annual installments of 25% each"
fully vested and exercisable financial
"are fully vested and exercisable as of the date of this report"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NNOX officer Dara James receive?
Nano-X Imaging Ltd. granted Dara James, GM Source & Services Division, 28,283 RSUs on October 11, 2026, under the 2019 Equity Incentive Plan. The award represents ordinary shares that vest and settle in four equal semi-annual installments, subject to continued employment on each vesting date.
What stock options did NNOX list for Dara James?
Nano-X Imaging lists direct options for 100,000 ordinary shares at $49.68, expiring January 18, 2031; 25,000 at $17.63, expiring March 28, 2032; 10,000 at $17.63, expiring August 11, 2032; and 55,000 at $11.52, expiring May 23, 2033. The first three positions were fully vested and exercisable; the 55,000-option award vests in 16 equal quarterly installments and will be exercisable by May 23, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
